Tee Corley, Author at Green Market Report

Tee CorleyTee CorleyJuly 21, 2020
Sublingual-Ketamine-1-1280x853.jpg

6min2170

The psychedelic industry is seeing a boom in the creation and expansion of ketamine clinics. The growth is in this industry has come about as the acceptance of the medical marijuana industry spread across North America. A group of medical professionals believes that this stigmatized substance may offer effective treatment for those suffering from mental health crises.

Known colloquially as special K, super acid, and cat valium, ketamine was added to the U.S. schedule of controlled substances in 1999. A “dissociative anesthetic,” ketamine has a street reputation for its dream-like high.

The illegal use of ketamine for recreation shrouds this medication in the familiar stigma that befell medical marijuana.

As the world changes and cases of mental health disorders rise, however, progressive medical researchers like Dr. Robert McIntyre of the Canadian Rapid Treatment Centre of Excellence (CRTCE) sees potential in ketamine for people who haven’t found relief with SSRIs, benzodiazepines or other prescription antidepressants and antianxiety medications.

What does the research say?

Dr. McIntyre recently released two new research studies in which patients suffering from suicidality, major depressive disorder (MDD), generalized anxiety disorder (GAD) and bipolar disorder (BD) were introduced to a new treatment: IV ketamine.

According to the researchers, these community trials were performed on patients who have previously tried prescription antidepressants in the past with little to no effect.

In February 2020, Dr. McIntyre and his team performed a review of the current data surrounding ketamine. The sheer number of trials the researchers analyzed, totalling 119 relevant and completed random clinical trials, suggests that Dr. McIntyre isn’t alone in recognizing the potential for IV ketamine.

Furthermore, these trials showed that IV ketamine given in a single dose of 0.5mg/kg over the course of 40 minutes had positive results lasting for a week. A few studies delivered 2 doses per week over the course of two weeks with positive results.

In his team’s study, published in May 2020, Dr. McIntyre and his team tested a single dose of IV ketamine on patients with treatment-resistant mood disorders. Specifically, this study measured the effects of IV ketamine on people with anxiety, irritability and agitation (AIA) and treatment-resistant major depressive disorder (MDD) and bipolar disorder (BD).

While the research is preliminary, with most studies, like this one, in phase II, the results are promising. Dr. McIntyre told us that these studies suggest “IV ketamine is effective in rapidly treating AIA and suicidal ideation in adults with treatment-resistant mood disorders.”

Why IV ketamine?

Yes, there are other ways for patients to get treatment with ketamine. Contacting your local dealer is not one of them.

Ketamine can be made into powders and pills, but these methods of administration are simply not as effective as taking ketamine intravenously and under the care of a medical professional. Dr. McIntyre explained that oral routes of administration are only about 10-20% bioavailable.

In March 2019, the FDA approved an intranasal form of ketamine called esketamine. This method is 50-60% absorbed by your body.

IV ketamine can be administered in under an hour and is 100% bioavailable. This means patients can get in and out and feeling better much more quickly and efficiently.

How soon will IV ketamine disrupt the pharmaceutical market?

Unfortunately, that’s a tough call to make. However, Dr. McIntyre points out that in the past decade, phase I, II and III trials have greatly increased. Phase III trials can make or break a product.

Still, Dr. McIntyre’s review of existing analyses shows what kinks still need to be resolved. For example, we have yet to control for size, weight and gender. Additionally, long term studies need to be conducted to determine the efficacy of repeated doses and how well ketamine is tolerated over time.

Our advice? Keep an eye on this market. The potential for a better way to treat complex mood disorders via IV ketamine seems apparent—an implication too important to ignore.


Tee CorleyTee CorleyJuly 14, 2020
X2_PCB_On_1080.jpg

8min3922

You’ve worked hard on your commercial grow space. Like a mad scientist, you test pH levels, precisely measure moisture, and strictly harvest your hemp at its peak maturity.

But when you’re growing large, leafy plants in tight spaces, finding the best lighting for your plants may be your biggest headache. Are your plants getting too little or too much light? Do you need to buy multiple lights to get you from seed to harvest? Can’t one light do it all?

Kind LED Lighting is declaring a resounding, “Yes!” Kind LED invites you to kick up your feet and rest your mind. This trusted brand has recently released the most important innovation in LED grow lamps since, well, LED lights. It’s called the X².

The Kind LED X² Difference

This commercial LED light was designed with the help of motivated engineers, agricultural scientists and hydroponic experts. Kind LED’s X² brought these fields together for revolutionary results: larger, more potent yields and a superior return on investment.

As the legal status of hemp and marijuana continues to relax, more entrepreneurs are trying their hands at commercial grow operations. Fortunately for new indoor farmers, the makers of the X², who have been growing commercially for several decades, have plenty of experience reconciling common problems.

Greenhouse and indoor grow operations are restricted by practical and scientific puzzles. For example, tight spaces can be hard to fill with light, especially as the canopy expands and provides shade for lower leaves. In turn, growers struggle to find the “right” amount of light. As the plant grows through its stages, it needs different lighting spectrums which could cost thousands in regular bar lights.

Naturally, balancing the intensity, heat and spectrum is too big of a job for a single grow lamp⁠—until now.

The X² steps ahead of the rest as it’s the only light you’ll need from seed to harvest. Fully tunable and customizable, the X² comes with an optional compatible 3-channel controller that gives you complete control over intensity and spectrum. And for those of you looking to scale your operation, rest assured that the controller can adjust over 500 X² lights simultaneously.

Built to accommodate gardeners with limited space, the X² utilizes three concentric squares made from LED light bars. This design ensures your plant is getting maximum photons from top to bottom.

The light that plants predominantly use for photosynthesis ranges from 400–700 nm. Referred to as Photosynthetically Active Radiation (PAR), this range includes red, blue and green wavebands, which match the LEDs on the X². With the X², you have full control over your spectrum.

With larger, healthier yields, you can expect a better return on your investment. LED lights always held promise for indoor gardeners. They’re cooler than standard HIDs and use about half of the electricity. Don’t waste money on high electricity bills from lighting and air conditioning.

With over 75,000 hours of lifetime use, you can expect to save money on replacing burnt out lamps, too. This LED light comes with a 5-year warranty to boot. The deluxe heatsink keeps your plants and electronic elements cool, preserving the life of your equipment for years to come.

Why is this grow lamp so important?

It wasn’t long ago that LED lights hit the market with promises of using less electricity while emitting intense light and keeping their cool.

But the people behind Kind LED, as well as many other cannabis growers, were quickly disappointed. They found LEDs didn’t have the intensity and spectrum needed to effectively grow large, potent plants. Forced back into using energy-sapping, heat-producing HIDs, Kind LED felt there must be another way.

Ever since, Kind LED has been leading the industry in LED lighting innovation. The promises of LED lighting may have been too good to be true, but they were also too good to ignore. Kind LED bar lights have now become the world’s number one selling LED grow lights, but they didn’t stop there.

The X2 is an important step in cost-saving, heat-reducing LED lighting. Kind LED’s engineers ensured that this light is intense or dim depending on your plants’ needs and within an effective PAR for healthy growth. This light eliminates the need to move plants to special grow stations based on their growth stage. The X² saves growers time, money, headaches and valuable space.

Kind LED Lighting X² Features & Specs

Let’s get down to the details. The specs on this LED grow lamp are impressive.

  • Dimensions: 39.4” x 39.4” x 4.3”
  • Weight: 40.2 lbs
  • Spectrum: 3-channel, fully adjustable
  • Has a true PPF of 1650 μmol/sec
  • Efficacy of 2.22 μmol/J
  • Max wattage: 750w
  • >75,000 lifetime hours
  • 5-year warranty
  • Control light spectrum, intensity and timing for more than 500 X2s with the compatible controller
  • Large heatsink keeps your plants and electronics cool
  • Retail price: $1,695; optional controller: $299.95

 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 10 hours

RT : 5 Powerful Uses for Cannabis by @greenmarketrpt

@GreenMarketRpt – 23 hours

$GRWG ⁦@GrowGenOK⁩ Stock Pops as Company Beats Analyst Estimates #cultivation…

@GreenMarketRpt – 1 day

The Daily Hit: August 12th, 2020

Back to Top

You have Successfully Subscribed!